Reference
Hirunagi T, et al. Anti-Mi-2 antibody-positive inflammatory myopathy during treatment with golimumab. Neurology and Clinical Neuroscience 6: 131-132, No. 5, Sep 2018. Available from: URL: http://doi.org/10.1111/ncn3.12202 -Japan
Rights and permissions
About this article
Cite this article
Golimumab. Reactions Weekly 1722, 164 (2018). https://doi.org/10.1007/s40278-018-52493-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-52493-2